¹Prof. Dr. Pamir DİRİL, ²Nuran Murat

¹St. Clements University/Department of Psychology Lecturer/Turkey
ORCID ID: 0000-0001-8913-343X

²PhD Student St. Clements University, Psychology
Orcıd ID No: 0009-0006-2921-3474

DOI : https://doi.org/10.58806/ijsshmr.2025.v4i12n07

Google Scholar Download Pdf
ABSTRACT

Addiction is much more than just a personal problem for individuals; it is also a multidimensional condition shaped by complex and multifaceted neurobiological processes, resulting in significant socio-cultural and economic consequences in society. This complex process progresses in a carefully interrelated manner, involving disruptions in the functioning of the brain's reward system, neurotransmitter imbalances, and environmental factors. These factors have the potential to create significant and noticeable changes in individuals' lives. In particular, detailed and comprehensive research conducted on the neurotransmitter dopamine, which plays a critical role in the brain and is known as the most fundamental element of reward mechanisms, has been an extremely important cornerstone in unravelling the complex processes and mechanisms of addiction in the brain. The brain's reward system plays a critical role in acquiring and reinforcing habits; in cases of addiction, significant changes are observed in the sensitivity of this system and its response to stimuli. Such changes can increase individuals' sensitivity to various stimuli, paving the way for the development and deepening of addiction. At this point, addiction not only creates a situation that negatively affects the individual's quality of life, but also causes significant impairments in decision-making ability, impulse control, regulation of reward expectations, and social relationships.

KEYWORDS:

neurobiological processes, brain reward system, neurotransmitters, socio-cultural consequences

REFERENCES

1) American Psychiatric Association and American Psychiatric Association DSM-5 Task Force. Diagnostic and Statistical Manual of Mental Disorders: DSM-5 Washington, DC American Psychiatric Association, 2013.

2) Harricharan R, Abboussi O, Daniels WMU. Addiction: A dysregulation of satiety and inflammatory processes. Prog Brain Res. 2017;235:65-91.

3) Koob GF. Neurobiological substrates for the dark side of compulsivity in addiction. Neuropharmacology. 2009;56 Suppl 1:18-31.

4) Koob GF, Volkow ND. Neurobiology of addiction: a neurocircuitry analysis. The Lancet Psychiatry. Lancet Psychiatry. 2016;3(8):760-73.

5) Volkow ND, Morales M. The Brain on Drugs: From Reward to Addiction. Cell. 2015;162(4):712-25.

6) UNODC. World Drug Report 2017. United Nations Office on Drugs and Crime. 2017.

7) van den Heuvel LL. Stahl’s essential psychopharmacology: Neuroscientific basis and practical applications 4th eds. J Child Adolesc Ment Heal. 2014.

8) Pariyadath V, Gowin JL, Stein EA. Resting state functional connectivity analysis for addiction medicine: From individual loci to complex networks. Prog Brain Res. 2016;224:155-73.

9) Koob GF. Drugs of abuse: anatomy, pharmacology and function of reward pathways. Trends Pharmacol Sci. 1992;13(5):177-84.

10) Margolis EB, Toy B, Himmels P, Morales M, Fields HL. Identification of rat ventral tegmental area GABAergic neurons. PLoS One. 2012;7(7): e42365.

11) Pistillo F, Clementi F, Zoli M, Gotti C. Nicotinic, glutamatergic and dopaminergic synaptic transmission and plasticity in the mesocorticolimbic system: Focus on nicotine effects. Prog Neurobiol. 2015;124:1-27.

12) Tritsch NX, Ding JB, Sabatini BL. Dopaminergic neurons inhibit striatal output through non-canonical release of GABA. Nature. 2012;11;490(7419):262-6.

13) Jaworski JN, Kozel MA, Philpot KB, Kuhar MJ. Intraaccumbal injection of CART (cocaine-amphetamine regulated transcript) peptide reduces cocaine-induced locomotor activity. J Pharmacol Exp Ther. 2003;307(3):1038-44.

14) Hubert GW, Jones DC, Moffett MC, Rogge G, Kuhar MJ. CART peptides as modulators of dopamine and psychostimulants and interactions with the mesolimbic dopaminergic system. Biochem Pharmacol. 2008;75(1):57–62.

15) Yager LM, Garcia AF, Wunsch AM, Ferguson SM. The ins and outs of the striatum: role in drug addiction. Neuroscience. 2015;20;301:529-41.

16) Howard CD, Li H, Geddes CE, Jin X. Dynamic Nigrostriatal Dopamine Biases Action Selection. Neuron. 2017;22:93(6):1436-50.

17) Koob GF, Everitt BJ, Robbins TW. Reward, Motivation, and Addiction. In: Fundamental Neuroscience: 4th eds. 2013.

18) Turton S, Lingford-Hughes A. Neurobiology and principles of addiction and tolerance. Medicine (United Kingdom). 2016;44(12):693–6.

19) Nestler EJ. Is there a common molecular pathway for addiction? Nat Neurosci. 2005;8(11):1445-9.

20) Koylu EO, Balkan B, Kuhar MJ, Pogun S. Cocaine and amphetamine regulated transcript (CAR)

VOlUME 04 ISSUE 12 December 2025